The global cell lysis & disruption market size is evaluated at USD 6.22 billion in 2025 and is forecasted to hit around USD 13.50 billion by 2034, growing at a CAGR of 9.00% from 2025 to 2034. The North America market size was accounted at USD 2.34 billion in 2024 and is expanding at a CAGR of 9.11% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Cell Lysis & Disruption Market, by Product Type,
7.1.1. Instruments
7.1.1.1. Market Revenue and Forecast
7.1.2. Reagents
7.1.2.1. Market Revenue and Forecast
8.1. Cell Lysis & Disruption Market, by Application,
8.1.1. Cell Organelle Isolation
8.1.1.1. Market Revenue and Forecast
8.1.2. Protein Isolation
8.1.2.1. Market Revenue and Forecast
8.1.3. Downstream Processing
8.1.3.1. Market Revenue and Forecast
8.1.4. Nucleic Acid Isolation
8.1.4.1. Market Revenue and Forecast
9.1. Cell Lysis & Disruption Market, by Cell Type,
9.1.1. Bacteria Cells
9.1.1.1. Market Revenue and Forecast
9.1.2. Mammalian Cells
9.1.2.1. Market Revenue and Forecast
9.1.3. Plant Cells
9.1.3.1. Market Revenue and Forecast
9.1.4. Yeast/Fungi/Algae
9.1.4.1. Market Revenue and Forecast
10.1. Cell Lysis & Disruption Market, by End Use Type,
10.1.1. End Use
10.1.1.1. Market Revenue and Forecast
10.1.2. Cell Banks
10.1.2.1. Market Revenue and Forecast
10.1.3. Academic and Research Institutions
10.1.3.1. Market Revenue and Forecast
10.1.4. Pharma & Biotechnology Companies
10.1.4.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product
11.1.2. Market Revenue and Forecast, by Application
11.1.3. Market Revenue and Forecast, by Cell Type
11.1.4. Market Revenue and Forecast, by End Use Type
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product
11.1.5.2. Market Revenue and Forecast, by Application
11.1.5.3. Market Revenue and Forecast, by Cell Type
11.1.5.4. Market Revenue and Forecast, by End Use Type
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product
11.1.6.2. Market Revenue and Forecast, by Application
11.1.6.3. Market Revenue and Forecast, by Cell Type
11.1.6.4. Market Revenue and Forecast, by End Use Type
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product
11.2.2. Market Revenue and Forecast, by Application
11.2.3. Market Revenue and Forecast, by Cell Type
11.2.4. Market Revenue and Forecast, by End Use Type
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product
11.2.5.2. Market Revenue and Forecast, by Application
11.2.5.3. Market Revenue and Forecast, by Cell Type
11.2.5.4. Market Revenue and Forecast, by End Use Type
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product
11.2.6.2. Market Revenue and Forecast, by Application
11.2.6.3. Market Revenue and Forecast, by Cell Type
11.2.6.4. Market Revenue and Forecast, by End Use Type
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product
11.2.7.2. Market Revenue and Forecast, by Application
11.2.7.3. Market Revenue and Forecast, by Cell Type
11.2.7.4. Market Revenue and Forecast, by End Use Type
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product
11.2.8.2. Market Revenue and Forecast, by Application
11.2.8.3. Market Revenue and Forecast, by Cell Type
11.2.8.4. Market Revenue and Forecast, by End Use Type
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product
11.3.2. Market Revenue and Forecast, by Application
11.3.3. Market Revenue and Forecast, by Cell Type
11.3.4. Market Revenue and Forecast, by End Use Type
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product
11.3.5.2. Market Revenue and Forecast, by Application
11.3.5.3. Market Revenue and Forecast, by Cell Type
11.3.5.4. Market Revenue and Forecast, by End Use Type
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product
11.3.6.2. Market Revenue and Forecast, by Application
11.3.6.3. Market Revenue and Forecast, by Cell Type
11.3.6.4. Market Revenue and Forecast, by End Use Type
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product
11.3.7.2. Market Revenue and Forecast, by Application
11.3.7.3. Market Revenue and Forecast, by Cell Type
11.3.7.4. Market Revenue and Forecast, by End Use Type
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product
11.3.8.2. Market Revenue and Forecast, by Application
11.3.8.3. Market Revenue and Forecast, by Cell Type
11.3.8.4. Market Revenue and Forecast, by End Use Type
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product
11.4.2. Market Revenue and Forecast, by Application
11.4.3. Market Revenue and Forecast, by Cell Type
11.4.4. Market Revenue and Forecast, by End Use Type
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product
11.4.5.2. Market Revenue and Forecast, by Application
11.4.5.3. Market Revenue and Forecast, by Cell Type
11.4.5.4. Market Revenue and Forecast, by End Use Type
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product
11.4.6.2. Market Revenue and Forecast, by Application
11.4.6.3. Market Revenue and Forecast, by Cell Type
11.4.6.4. Market Revenue and Forecast, by End Use Type
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product
11.4.7.2. Market Revenue and Forecast, by Application
11.4.7.3. Market Revenue and Forecast, by Cell Type
11.4.7.4. Market Revenue and Forecast, by End Use Type
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product
11.4.8.2. Market Revenue and Forecast, by Application
11.4.8.3. Market Revenue and Forecast, by Cell Type
11.4.8.4. Market Revenue and Forecast, by End Use Type
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product
11.5.2. Market Revenue and Forecast, by Application
11.5.3. Market Revenue and Forecast, by Cell Type
11.5.4. Market Revenue and Forecast, by End Use Type
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product
11.5.5.2. Market Revenue and Forecast, by Application
11.5.5.3. Market Revenue and Forecast, by Cell Type
11.5.5.4. Market Revenue and Forecast, by End Use Type
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product
11.5.6.2. Market Revenue and Forecast, by Application
11.5.6.3. Market Revenue and Forecast, by Cell Type
11.5.6.4. Market Revenue and Forecast, by End Use Type
12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Danaher Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Qiagen NV
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Parr Instrument Company
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Covaris Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Merck KGaA
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Bio-Rad Laboratories
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. F. Hoffmann-La Roche Ltd.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Claremont BioSolutions
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Becton Dickinson & Company
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample